🇺🇸 FDA
Pipeline program

E0302 SR1

E0302-J064-003

Phase 1 small_molecule completed

Quick answer

E0302 SR1 for Healthy Subjects is a Phase 1 program (small_molecule) at Eisai Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Eisai Co.,
Indication
Healthy Subjects
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials